核苷类似物治疗儿童朗格罕细胞组织细胞增生症
摘要
朗格罕细胞组织细胞增生症（Langerhans cell histiocytosis，LCH）是一组由朗格罕细胞为主的组织细胞在机体网状内皮系统内广泛增生、浸润为基本特征的疾病，全身各器官、系统均可受累，其中肝、脾、血液系统和肺被认为是受累的危险器官［1］。LCH的异质性很强，单系统和（或）无危险器官受累患儿对常规治疗反应好，个别甚至可自愈，长期生存率在90％以上，而多系统尤其伴危险器官受累的高危患儿对常规化疗反应不佳，成为难治或复发病例，预后不良［2］。近些年，陆续报道了核苷类似物对难治和复发LCH患者的挽救治疗及一线治疗，效果令人振奋。本文就此方面进展进行综述。
出处
《中国小儿血液与肿瘤杂志》
CAS
2014年第6期283-286,共4页
Journal of China Pediatric Blood and Cancer
参考文献20
-
1Abla O,Egeler RM,Weitzman S.Langerhans cell histiocytosis:current concepts and treatments.Cancer Treat Rev,2010,36:354-359.
-
2Kim BE,Koh KN,Suh JK.Clinical features and treatment outcomes of Langerhans cell histiocytosis:a nationwide survey from Korea histiocytosis working party.J Pediatr Hematol Oncol,2014,36:125-133.
-
3Zenhusern R,Schmitz SF,Solenthaler M,et al.Randomized trial of daily versus weekly administration of 2-chlorodeoxyadenosine in patients with hairy cell leukemia:a multicenter phaseⅢtrial(SAKK32/98).Leuk Lymphoma,2009,50:1501-1511.
-
4Kalinka-Warzocha E,Wajs J,Lech-Maranda E,et al.Polish Lymphoma Research Group.Randomized comparison of cladribine alone or in combination with cyclophosphamide,and cyclophosphamide,vincristine and prednisone in previously untreated low-grade B-cell non-Hodgkin lymphoma patients.Final report of the Polish Lymphoma Research Group.Cancer,2008,113:367-375.
-
5Holowiecki J,Grosicki S,Giebel S,et al.Cladribine,but not fludarabinr,added to daunorubicin and cytarabine during induction prolongs survival of patients with acute myeloid leukemia:a multicenter,randomized phaseⅢstudy..J Clin Oncol,2012,30:2441-2448.
-
6Minkov M,Steiner M,Potschger U.Reactivations in multisystem Langerhans cell histiocytosis:data of the international LCH registry.J Pediatr,2008,153:700-705.
-
7Saven A,Figueroa ML,Piro LD,et al.2-Chlorodeoxyadenosine to Treat Refractory Histiocytosis X.N Engl J Med,1993,329:734-735.
-
8Stine KC,Saylors RL,Williams LL,et al.2-Chlorodeoxyadenosine(2-CDA)for the treatment of refractory or recurrent Langerhans cell histiocytosis(LCH)in pediatric patients.Med Pediater Oncol,1997,29:288-292.
-
9Weitzman S,Wayne AS,Arceci R,et al.Nucleoside analogues in the therapy of Langerhans cell histiocytosis:a survey of members of the histiocyte society and review of the literature.Med Pediatr Oncol,1999,33:476-481.
-
10Saven A and Burian C.Cladribine activity in adult Langerhans-cell histiocytisis.Blood,1999,93:4125-4130.
-
1丁甫月,李晖,郑华兰.朗格罕细胞组织细胞增生症28例临床分析[J].中国小儿血液,2001,6(1):21-22. 被引量：1
-
2刘玉峰,李云霞,方营旗,盛光耀.朗格罕细胞组织细胞增生症伴严重肝损害1例[J].中国小儿血液,2000,5(2):75-75. 被引量：1
-
3高巧娣,陆凤娟,吴长根,马伴吟,吴玥.小儿郎格罕细胞组织细胞增生症32例临床分析[J].临床儿科杂志,2005,23(2):94-97. 被引量：8
-
4王嘉怡,黄儒霖,陈峥嵘.p16基因在朗格罕细胞组织细胞增生症发病机制中的作用[J].广东医学,2013,34(20):3145-3147. 被引量：1
-
5许松涛,盛光耀,赵晓明,邹湘,白松婷.朗格罕细胞组织细胞增生症25例临床分析[J].中华妇幼临床医学杂志（电子版）,2010,6(1):50-52. 被引量：1
-
6孟静媛,李向飞,闫文娟.新生儿组织细胞增生症1例[J].医学理论与实践,2005,18(3):359-359.
-
7邱乾德.孤立性甲状腺朗格罕细胞组织细胞增生症一例[J].放射学实践,2009,24(11):1231-1231. 被引量：1
-
8王宇,贾继东.朗格罕细胞组织细胞增生症硬化性胆管炎一例[J].中华医学信息导报,2011,26(14):21-22.
-
9廖伟伟,钟雪梅,马昕,宁慧娟,张艳玲.以硬化性胆管炎为首发表现的儿童朗格罕细胞组织细胞增生症1例并文献复习[J].北京医学,2015,37(6):551-554.
-
10翟晓,钟美佐,黄进,齐振华.朗格罕细胞组织细胞增生症三例误诊分析[J].临床误诊误治,2005,18(8):573-574. 被引量：2
